Blog
Vir Biotechnology, Inc. (VIR) Reports Q3 Loss, Misses Revenue Estimates
Vir Biotechnology, Inc. (VIR) came out with a quarterly loss of $1.17 per share versus the Zacks Consensus Estimate of a loss of $0.7. This compares to a loss of $1.56 per share a year ago. These
PDD Holdings Inc. Sponsored ADR (PDD) Laps the Stock Market: Here's Why
PDD Holdings Inc. Sponsored ADR (PDD) closed at $136.34 in the latest trading session, marking a +1.87% move from the prior day. This move outpaced the S&P 500's daily gain of 0.37%. On the other
Grand Canyon Education (LOPE) Meets Q3 Earnings Estimates
Grand Canyon Education (LOPE) came out with quarterly earnings of $1.78 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $1.48 per share a year ago. These figures
Nvidia (NVDA) Stock Sinks As Market Gains: What You Should Know
Nvidia (NVDA) closed the most recent trading day at $195.19, moving -1.76% from the previous trading session. The stock's change was less than the S&P 500's daily gain of 0.37%. Meanwhile, the Dow
Lowe's (LOW) Stock Sinks As Market Gains: Here's Why
Lowe's (LOW) closed at $234.35 in the latest trading session, marking a -1.43% move from the prior day. This change lagged the S&P 500's daily gain of 0.37%. Meanwhile, the Dow gained 0.48%, and the
Dell Technologies (DELL) Stock Falls Amid Market Uptick: What Investors Need to Know
Dell Technologies (DELL) closed at $152.41 in the latest trading session, marking a -1.44% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.37% for the day
Host Hotels (HST) Q3 FFO and Revenues Top Estimates
Host Hotels (HST) came out with quarterly funds from operations (FFO) of $0.35 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to FFO of $0.36 per share a year ago
BlackBerry (BB) Laps the Stock Market: Here's Why
In the latest trading session, BlackBerry (BB) closed at $4.75, marking a +1.71% move from the previous day. This change outpaced the S&P 500's 0.37% gain on the day. Meanwhile, the Dow gained
Catalyst Pharmaceutical (CPRX) Beats Q3 Earnings and Revenue Estimates
Catalyst Pharmaceutical (CPRX) came out with quarterly earnings of $0.68 per share, beating the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.57 per share a year ago
Chewy (CHWY) Stock Drops Despite Market Gains: Important Facts to Note
Chewy (CHWY) closed at $33.07 in the latest trading session, marking a -2.13% move from the prior day. The stock's change was less than the S&P 500's daily gain of 0.37%. Elsewhere, the Dow gained
Baidu Inc. (BIDU) Stock Declines While Market Improves: Some Information for Investors
Baidu Inc. (BIDU) closed the most recent trading day at $123.33, moving -1.33% from the previous trading session. The stock's performance was behind the S&P 500's daily gain of 0.37%. Meanwhile, the
CF Industries (CF) Q3 Earnings Beat Estimates
CF Industries (CF) came out with quarterly earnings of $2.19 per share, beating the Zacks Consensus Estimate of $2.06 per share. This compares to earnings of $1.55 per share a year ago. These
Broadcom Inc. (AVGO) Beats Stock Market Upswing: What Investors Need to Know
Broadcom Inc. (AVGO) closed at $358.98 in the latest trading session, marking a +2% move from the prior day. The stock exceeded the S&P 500, which registered a gain of 0.37% for the day. Elsewhere
Ameren (AEE) Q3 Earnings and Revenues Surpass Estimates
Ameren (AEE) came out with quarterly earnings of $2.17 per share, beating the Zacks Consensus Estimate of $2.1 per share. This compares to earnings of $1.87 per share a year ago. These figures are
Keros Therapeutics, Inc. (KROS) Reports Q3 Loss, Tops Revenue Estimates
Keros Therapeutics, Inc. (KROS) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $1.11. This compares to a loss of $1.41 per share a year ago. These
Gladstone Land (LAND) Surpasses Q3 FFO and Revenue Estimates
Gladstone Land (LAND) came out with quarterly funds from operations (FFO) of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.03 per share. This compares to FFO of $0.13 per
Genco Shipping & Trading (GNK) Reports Q3 Loss, Misses Revenue Estimates
Genco Shipping & Trading (GNK) came out with a quarterly loss of $0.01 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.41 per share a year ago. These figures are
NCR Atleos (NATL) Q3 Earnings and Revenues Beat Estimates
NCR Atleos (NATL) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $1.01 per share. This compares to earnings of $0.89 per share a year ago. These figures
Xencor (XNCR) Reports Q3 Loss, Misses Revenue Estimates
Xencor (XNCR) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.72. This compares to a loss of $0.71 per share a year ago. These figures are
Jazz Pharmaceuticals (JAZZ) Q3 Earnings and Revenues Beat Estimates
Jazz Pharmaceuticals (JAZZ) came out with quarterly earnings of $8.13 per share, beating the Zacks Consensus Estimate of $5.74 per share. This compares to earnings of $6.61 per share a year ago
Gossamer Bio (GOSS) Reports Q3 Loss, Tops Revenue Estimates
Gossamer Bio (GOSS) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $0.14 per share a year ago. These figures are
Fair Isaac (FICO) Surpasses Q4 Earnings and Revenue Estimates
Fair Isaac (FICO) came out with quarterly earnings of $7.74 per share, beating the Zacks Consensus Estimate of $7.34 per share. This compares to earnings of $6.54 per share a year ago. These figures
Envela Corporation (ELA) Tops Q3 Earnings and Revenue Estimates
Envela Corporation (ELA) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.06 per share a year ago. These
Alpha and Omega Semiconductor (AOSL) Q1 Earnings Beat Estimates
Alpha and Omega Semiconductor (AOSL) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.21 per share a year
Dianthus Therapeutics, Inc. (DNTH) Reports Q3 Loss, Lags Revenue Estimates
Dianthus Therapeutics, Inc. (DNTH) came out with a quarterly loss of $0.97 per share versus the Zacks Consensus Estimate of a loss of $0.86. This compares to a loss of $0.74 per share a year ago


